The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease
Year: 2017
Type: article
Source: Kidney International Supplements
Institutions: The University of Sydney, Akebia Therapeutics (United States), LMU Klinikum, Ludwig-Maximilians-Universität München, Shariati Hospital, Tehran University of Medical Sciences, Translational Research Institute, The University of Queensland, Princess Alexandra Hospital, University of Minnesota, Hennepin County Medical Center, Monash University, Pontifícia Universidade Católica do Paraná, University of Milan, Mario Negri Institute for Pharmacological Research, Ospedale Papa Giovanni XXIII, Juntendo University, The University of Tokyo, University of Otago, Chang Gung University, Chang Gung Memorial Hospital, Linkou Chang Gung Memorial Hospital, Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2756358100